Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder

The selective serotonin reuptake inhibitor escitalopram (ESC) is indicated for the treatment of major depressive disorder (MDD) and of generalized anxiety disorder (GAD). Monitoring of blood levels (BLs) is strongly indicated due to ESC’s high interindividual pharmacokinetic variability. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hart, X. M., Heesen, S., Schmitz, C. N., Dörfler, S., Wedekind, D., Gründer, G., Hiemke, C., Havemann-Reinecke, U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958172/
https://www.ncbi.nlm.nih.gov/pubmed/36207527
http://dx.doi.org/10.1007/s00406-022-01491-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958172/
https://www.ncbi.nlm.nih.gov/pubmed/36207527
http://dx.doi.org/10.1007/s00406-022-01491-9

Ejemplares similares